Delivery Order SPE2DB22D1017-SPE2DB24FG3UV

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $2,699.47. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $1,891.24. The contract is a firm fixed price delivery order with a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Fluticasone Prop HFA 110 MCG 12GM. The contract is a firm fixed-price delivery order with a ceiling value of $2,745.80 and a completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, and has a ceiling value of $1,631.76. The contract is a firm fixed price delivery order with an ultimate completion date of April 16, 2025. This award is not set-aside and is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.50, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of January 30, 2025. This award is not associated with a set-aside designation. In addition to this specific delivery order,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $2,432.11 and a completion date of September 3, 2024. The award is not associated with a set-aside program. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of Fluticasone Prop HFA 110 MCG 12GM. The award, valued at $3,131.16, is a firm fixed price contract with an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has significant experience supplying medical products to federal government agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $12,871.25. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 110 MCG 12GM. The contract has a ceiling value of $1,174.15 and an ultimate completion date of April 18, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,297.40 and an ultimate completion date of February 7, 2024. This contract award is not associated with a set-aside...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3UV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a prescription medication. The firm-fixed-price delivery order has a ceiling value of $5,892.99 and an ultimate completion date of August 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is likely part of that broader IDC vehicle, enabling the DLA to efficiently procure essential pharmaceutical products from AmerisourceBergen to support the healthcare needs of military personnel and other federal beneficiaries.

Generated 11/21/24, 9:29 AM